FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102186 [Registered on: 27/01/2026] Trial Registered Prospectively
Last Modified On: 27/01/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Screening
Other (Specify) 
Study Design  Single Arm Study 
Public Title of Study   Visual outcomes after implantation of two different advanced intraocular lenses, one in each eye 
Scientific Title of Study   Visual outcomes of Capsulotomy Fixated EDOF (extended depth of focus) in one eye and Capsulotomy Fixated Multifocal intraocular lenses in the other eye 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sri ganesh  
Designation  Chief Medical Director  
Affiliation  Nethradhama superspeciality eye hospital  
Address  Nethradhama Super Speciality Eye Hospital, Phacorefractive Department, OPD Division, Room number 202, 256/14, Kanakapura Rd, 7th Block, Jayanagar, Bengaluru Bangalore KARNATAKA 560041 India

Bangalore
KARNATAKA
560070
India 
Phone  9845129740  
Fax    
Email  phacomaverick@gmail.com   
 
Details of Contact Person
Scientific Query
 
Name  Dr Shreya Pai 
Designation  Fellows  
Affiliation  Nethradhama superspeciality eye hospital  
Address  Nethradhama Super Speciality Eye Hospital, Phacorefractive Department, OPD Division, Room number 202, 256/14, Kanakapura Rd, 7th Block, Jayanagar, Bengaluru Bangalore KARNATAKA 560041 India

Bangalore
KARNATAKA
560070
India 
Phone  9738712712  
Fax    
Email  shreyaspai97@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shreya Pai 
Designation  Fellows  
Affiliation  Nethradhama superspeciality eye hospital  
Address  Nethradhama Super Speciality Eye Hospital, Phacorefractive Department, OPD Division, Room number 202, 256/14, Kanakapura Rd, 7th Block, Jayanagar, Bengaluru Bangalore KARNATAKA 560041 India


KARNATAKA
560070
India 
Phone  9738712712  
Fax    
Email  shreyaspai97@gmail.com  
 
Source of Monetary or Material Support  
Nethradhama superspeciality eye hospital, Kanakapura road, 7th block, Jayanagar, Bengaluru, Karnataka, India, 560070  
 
Primary Sponsor  
Name  Nethradhama Superspeciality Eye Hopsital  
Address  Nethradhama superspeciality eye hospital, Kanakapura road, 7th block, Jayanagar, Bengaluru, Karnataka, India, 560070 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shreya Pai  Nethradhama superspeciality eye hospital   Nethradhama superspeciality eye hospital, Kanakapura road, 7th block, Jayanagar, Bengaluru, Karnataka, India, 560070
Bangalore
KARNATAKA 
9738712712

shreyaspai97@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  To analyse the Visual and Refractive Outcome following the implantation of Femtis Comfort in one Eye and Femtis Mplus in the Second Eye.   Phacoemulsification of the nucleus will be done and coaxial I&A will be used to remove cortex. Hydro polish of the posterior capsule of the bag will be done. Implantation with Femtis Comfort or Femtis Mplus IOL will be done under BSS and the IOLs will be clipped to the anterior capsulotomy with a Sinsky. In case of toric IOL, placement will be guided by Intelliaxis technology which provides 2 refractive marks on the capsulotomy in the desired axis, eliminating the need for manual ink markings on the cornea; and by the Callisto markerless system in the Artevo 800 operating microscope (Carl Zeiss Meditec, Germany)  
Comparator Agent  To assess Contrast sensitivity and patient satisfaction after binocular implantation of the IOLs.  Phacoemulsification of the nucleus will be done and coaxial I&A will be used to remove cortex. Hydro polish of the posterior capsule of the bag will be done. Implantation with Femtis Comfort or Femtis Mplus IOL will be done under BSS and the IOLs will be clipped to the anterior capsulotomy with a Sinsky. In case of toric IOL, placement will be guided by Intelliaxis technology which provides 2 refractive marks on the capsulotomy in the desired axis, eliminating the need for manual ink markings on the cornea; and by the Callisto markerless system in the Artevo 800 operating microscope (Carl Zeiss Meditec, Germany) 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  • Bilateral senile cataract undergoing bilateral IOL Implantation (Second eye surgery within 10 +/- 4 days)
• Regular corneal topography and corneal astigmatism from 0.75 D to 4.00 D
• Availability, willingness and sufficient cognitive awareness to comply with examination procedures.
• Signed informed consent.
 
 
ExclusionCriteria 
Details  • Active ocular disease in the operative eye, for example, chronic uveitis, proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication, corneal decompensation and corneal endothelial cell insufficiency
• Subjects with any systemic disease that could increase operative risk or confound the outcome.
• Pregnant or lactating or planning a pregnancy at the time of enrolment.
• Any patient who is taking part in another study involving ocular surgery
• Significant irregular corneal astigmatism- Keratoconus/ post refractive surgery/ post LASIK ectasia
• Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under Mesopic/scotopic conditions)
• Retinal pathologies
• Glaucoma or disc abnormalities
• Zonular weakness/ subluxation or dislocation of lens
• Iris abnormalities such as coloboma.
• Patient not willing to give consent or not complying with follow up schedule.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To analyse the Visual and Refractive Outcome following the implantation of Femtis Comfort in one Eye and Femtis Mplus in the Second Eye.   performed on day 1, day 15 and 3 month 
 
Secondary Outcome  
Outcome  TimePoints 
To assess Contrast sensitivity and patient satisfaction after binocular implantation of the IOLs.
To analyse and check for subjective dysphotopsia and post operative satisfaction following the implantation of Femtis Comfort in one Eye and Femtis Mplus in the Second Eye.
 
performed on day 1, day 15 and 3 month 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Sample Size

The required sample size was calculated using G Power version 3.1.9.7 for a two tailed dependent paired sample t test. An effect size of Cohen d equal to 0.394 was considered clinically meaningful based on available literature. The sample size calculation was based on standard statistical principles, where Z alpha represents the standard normal deviate for the selected significance level and Z beta represents the standard normal deviate for the desired statistical power. The level of significance was fixed at 0.05 and the power of the study was set at 0.80. Based on these parameters, the minimum required sample size was estimated to be 53 subject pairs. To compensate for an anticipated dropout rate of ten percent, the final sample size was increased to 60 subject pairs, corresponding to a total of 120 eyes, with one eye per subject included in the analysis. This sample size was considered adequate to detect a moderate effect with sufficient statistical power.

Intraoperative Procedure

All enrolled subjects will undergo bilateral femtosecond laser assisted cataract surgery using either the LENSAR femtosecond laser system or the FEMTO LDV Z8 femtosecond laser system. A minimum capsulorrhexis diameter of five millimeters will be created using the femtosecond laser. A temporal clear corneal incision of two point eight millimeters and a single side port incision will be made. Phacoemulsification of the crystalline lens nucleus will be performed, followed by cortical aspiration using coaxial irrigation and aspiration. Posterior capsular polishing will be carried out. Intraocular lens implantation with either Femtis Comfort or Femtis Mplus lenses will be performed under balanced salt solution, and the lenses will be fixated to the anterior capsulotomy using a Sinskey hook. In cases where toric intraocular lenses are implanted, axis alignment will be guided using Intelliaxis technology, which provides refractive reference marks on the capsulotomy, thereby eliminating the need for manual corneal ink marking. Additional alignment assistance will be provided by the Callisto markerless system integrated into the Artevo 800 operating microscope.

Specifications of Study Lenses

Femtis Comfort is a foldable one piece aspheric extended depth of focus intraocular lens with additional capsulotomy fixation.
Femtis Mplus is a foldable one piece aspheric multifocal intraocular lens with additional capsulotomy fixation.

Both lenses are made of hydrophilic acrylic material with a hydrophobic surface coating. The optic diameter is five point seven millimeters, with an overall length of ten point five millimeters. Both lenses have zero degree haptic angulation and a refractive index of one point four six. The intraocular lens design consists of a plate haptic with additional clip haptics. The near addition is one point five diopters for Femtis Comfort and three point zero diopters for Femtis Mplus.

Clinical Endpoints

Assessment of uncorrected distance visual acuity, corrected distance visual acuity, intermediate visual acuity and near visual acuity.
Postoperative manifest refraction including sphere, cylinder and spherical equivalent.
Contrast sensitivity evaluation.

Postoperative Examinations

Postoperative assessments will be conducted on day one, day fifteen and at three months.

Uncorrected distance visual acuity using the ETDRS chart for monocular and binocular vision at all visits.
Best corrected distance visual acuity using the ETDRS chart for monocular and binocular vision at all visits.
Measurement of intraocular pressure using a non contact tonometer at all visits.
Slit lamp examination at all visits.
Manifest refraction measured in diopters on day fifteen and at three months.
Near vision assessment at thirty three centimeters using the ETDRS chart at all visits.
Intermediate vision assessment at forty, sixty and eighty centimeters using the ETDRS chart at all visits.
Dilated fundus examination on day fifteen and at three months.
Assessment of intraocular lens rotation using dilated slit lamp examination on day fifteen and at three months.
Dilated clinical photography for posterior capsular opacification assessment at three months.
Defocus curve analysis for monocular and binocular vision on day fifteen and at three months.
Contrast sensitivity testing using CSV one thousand on day fifteen and at three months.
Subjective patient satisfaction questionnaire administered on day fifteen.

Grading of Posterior Capsular Opacification

Grade one includes no or minimal posterior capsular opacification without reduction of the red reflex and absence of Elschnig pearls or pearls not reaching the intraocular lens edge.
Grade two includes mild posterior capsular opacification with reduced red reflex and presence of Elschnig pearls reaching the intraocular lens edge.
Grade three includes moderate fibrosis or Elschnig pearls within the intraocular lens edge but with a clear visual axis.
Grade four includes severe fibrosis or Elschnig pearls involving the visual axis with marked reduction of the red reflex.

Statistical Analysis

All statistical analyses will be performed using Python version three point one two and Jamovi version two point five. Normality of continuous variables will be assessed using the Kolmogorov Smirnov test, with support from the Central Limit Theorem where applicable. Continuous data will be expressed as mean and standard deviation, while categorical data will be presented as frequencies and percentages. Within group comparisons will be performed using the paired t test. Analysis of variance will be used for comparisons involving more than two groups. Non parametric tests will be applied for data that do not follow a normal distribution. A two tailed probability value of less than zero point zero five will be considered statistically significant.

 
Close